Dimensional Fund Advisors LP C4 Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 523,931 shares of CCCC stock, worth $916,879. This represents 0.0% of its overall portfolio holdings.
Number of Shares
523,931
Previous 578,885
9.49%
Holding current value
$916,879
Previous $3.3 Million
42.83%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CCCC
# of Institutions
125Shares Held
62.7MCall Options Held
651KPut Options Held
115K-
Soleus Capital Management, L.P. Greenwich, CT6.98MShares$12.2 Million1.75% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.85MShares$12 Million9.58% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.07MShares$10.6 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.88MShares$8.54 Million0.28% of portfolio
-
Black Rock Inc. New York, NY4.55MShares$7.97 Million0.0% of portfolio
About C4 Therapeutics, Inc.
- Ticker CCCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,913,800
- Market Cap $85.6M
- Description
- C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...